Clinical Trial: A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07709897) titled 'A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting' on July 08.

Brief Summary: The study is being conducted to evaluate the efficacy of HRS5580 for injection combined with palonosetron hydrochloride in the prevention of postoperative nausea and vomiting, and to explore the effective dose of HRS5580 for injection combined with palonosetron hydrochloride for the prevention of postoperative nausea and vomiting.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Prevention of Postoperative Nausea and Vomiting

Intervention: DRUG:...